Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review
Pharmacological Research · 2024-08 · 206 · 107282
DOI: 10.1016/j.phrs.2024.107282 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-08. Verfasst von Mengzhou Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), K…. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Receptor for Advanced Glycation End Products, Inflammation, Signal Transduction. Die Arbeit wurde bisher 276-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: State Key Laboratory of Tea Plant Biology and Utilization, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic inflammation is a common foundation for the development of many non-communicable diseases, particularly diabetes, atherosclerosis, and tumors. The activation of the axis involving Advanced Glycation End products (AGEs) and their receptor RAGE is a key promotive factor in the chronic inflammation process, influencing the pathological progression of these diseases. The accumulation of AGEs in the body results from an increase in glycation reactions and oxidative stress, especially pronounced in individuals with diabetes. By binding to RAGE, AGEs activate signaling pathways such as NF-κB, promoting the release of inflammatory factors, exacerbating cell damage and inflammation, and further advancing the formation of atherosclerotic plaques and tumor development. This review will delve into the molecular mechanisms by which the AGEs-RAGE axis activates chronic inflammation in the aforementioned diseases, as well as strategies to inhibit the AGEs-RAGE axis, aiming to slow or halt the progression of chronic inflammation and related diseases. This includes the development of AGEs inhibitors, RAGE antagonists, and interventions targeting upstream and downstream signaling pathways. Additionally, the early detection of AGEs levels and RAGE expression as biomarkers provides new avenues for the prevention and treatment of diabetes, atherosclerosis, and tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Industrial Microbiology, Cooperative Innovation Center of Industrial Fermentation (Ministry of Education & Hubei Province), Key Laboratory of Fermentation Engineering (Ministry of Education), Nat…
- Wuhan Caidian District Public Inspection and Testing Center, Wuhan, Hubei 430068, PR China.
- Hubei Standardization and Quality Institute, Wuhan,Hubei 430068, PR China.
Förderung
- State Key Laboratory of Tea Plant Biology and Utilization
- National Natural Science Foundation of China
Zitieren
APA
Zhou, M., Zhang, Y., Shi, L., Li, L., Zhang, D., Gong, Z., & Wu, Q. (2024). Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review. Pharmacological Research, 206, 107282. https://doi.org/10.1016/j.phrs.2024.107282
Vancouver
Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, et al. Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review. Pharmacological Research. 2024;206:107282. doi:10.1016/j.phrs.2024.107282
BibTeX
@article{Zhou2024,
author = {Zhou, Mengzhou and Zhang, Yuyan and Shi, Lin and Li, Liangchao and Zhang, Duo and Gong, Zihao and Wu, Qian},
title = {Activation and modulation of the AGEs-RAGE axis: Implications for inflammatory pathologies and therapeutic interventions – A review},
journal = {Pharmacological Research},
year = {2024},
volume = {206},
pages = {107282},
doi = {10.1016/j.phrs.2024.107282}
}
EUVIMED